BioNTech Authorizes $1 Billion ADS Repurchase Program Through May 2027
BioNTech has authorized a new ADS repurchase program allowing up to $1.0 billion in buybacks through May 6, 2027. The Company plans open market purchases funded by existing cash to enhance capital efficiency and support long-term value creation while meeting routine obligations.
1. ADS Repurchase Program Authorized
BioNTech’s board approved a share repurchase program to acquire up to $1.0 billion of American Depositary Shares, each representing one ordinary share, with transactions permitted through May 6, 2027.
2. Funding and Execution
Repurchases may occur in open market purchases when price efficient and will be funded entirely from existing cash resources to ensure disciplined capital deployment.
3. Strategic Rationale
The program is designed to enhance capital efficiency, support sustainable value creation and maintain financial flexibility while enabling BioNTech to satisfy obligations and advance its multi-product pipeline.